Healthcare Pricing Disclosures
MorphoSys fully adheres to the federal, state, and local laws and regulations that govern what we do, including those that govern healthcare pricing and disclosures of costs.
Wholesale Acquisition Cost (WAC) represents the manufacturer’s published list price for a drug product to wholesalers or distributors, as reported to third party drug price compendia. WAC does not represent actual transaction prices and does not include discounts, rebates, or other reductions in price. In many cases, the price paid by patients will be different from the reported WAC. How much a patient pays will depend on the patient’s insurance coverage. To determine the exact cost of a prescription, patients should contact their health insurance provider or specialty pharmacy.
Colorado Disclosure Act
This information is intended for Colorado prescribers.
Colorado law HB 19-1131 requires the manufacturer, when engaging in prescription drug marketing to Colorado prescribers, to provide Colorado prescribers with the WAC of the manufacturer prescription drug. Also, the manufacturer must provide the names of at least three generic prescription drugs, if available, from the same therapeutic class (i.e., similar drugs that have the same or similar mechanism of action used to treat a specific condition).
Connecticut Healthcare Disclosure Act
This information is intended for Connecticut prescribers and pharmacists.
Connecticut Public Act No. 23-171 requires the manufacturer, when engaging in prescription drug marketing to Connecticut prescribers and pharmacists, to provide a written disclosure of the WAC of our marketed prescription drug, based on the dose and quantity of the drug as described in the medication package insert, and, if available, information on the variation efficacy of the drug marketed to different racial and ethnic groups.
This portion of the MorphoSys website is intended for U.S. residents only. It is not for individuals living in Germany or other European Union member states.